Albinterferon alfa-2b

Drug Profile

Albinterferon alfa-2b

Alternative Names: ABF 656; Albuferon; Albuferon-α; Albumin-interferon alfa; Albumin/interferon-alpha fusion protein - Human Genome Sciences/Novartis; Interferon-alpha/albumin fusion protein - Human Genome Sciences/Novartis; Joulferon; Zalbin

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Human Genome Sciences
  • Developer Human Genome Sciences; Novartis
  • Class Albumins; Antineoplastics; Antivirals; Interferons; Recombinant fusion proteins
  • Mechanism of Action Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis B; Hepatitis C

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 03 Aug 2012 Human Genome Sciences has been acquired by GlaxoSmithKline
  • 06 Oct 2010 Discontinued - Phase-I for Hepatitis C in Japan (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top